Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
In dual-agonist and triple-agonist research, it may contribute to a broader incretin response than GLP-1 alone
BPC-157 has been characterized in over 100 published animal studies spanning gastrointestinal, musculoskeletal, vascular, and neural injury models
Background Information Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that plays a critical role in glucose homeostasis and energy balance
6 Intravenously infused GLP-1 slows gastric emptying, 7 reduces appetite and food intake, 8 and suppresses glucagon (GCG) secretion at normal and high blood glucose concentrations, but not during hypoglycaemia
A phase 1/2 study of lazertinib 240 mg in patients with advanced EGFR T790M-positive NSCLC after previous EGFR tyrosine kinase inhibitors
US$ 27.05
US$ 25.71
US$ 21.37
